Concepedia

Julie Vanbockstael

JV

3

Publications

253

Citations

3

H-Index

2015

Active since

Affiliations

Centre François Baclesse(Current)

Inserm

Institut de Recherche en Cancérologie de Montpellier

Institut de Cancérologie de Lorraine

Centre Antoine Lacassagne

Julie Vanbockstael is an author at Centre François Baclesse specializing in oncology, medicine, and radiation oncology.

Top concepts

MedicineOncologyHealthRadiologyCancer TherapyCancer ResearchPharmacotherapyGastroenterologyRadiation OncologyNeoadjuvant Therapy

Publications per year

2015–2021

3

Publications

3

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

J. Guigay, Anne Aupérin, Jérôme Fayette et al. · The Lancet Oncology · 2021 · 214 citations

Gortec 2014-01 Tpextreme, Neoadjuvant Therapy, Medicine +11

Association of COVID-19 Lockdown With the Tumor Burden in Patients With Newly Diagnosed Metastatic Colorectal Cancer

Alain R. Thierry, Brice Pastor, Ekaterina Pisareva et al. · JAMA Network Open · 2021 · 24 citations · Full text

How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study

Julie Vanbockstael, Elodie Coquan, Sophie Gouérant et al. · Supportive Care in Cancer · 2015 · 15 citations

Chemotherapy-induced Nausea, French Navi Study, Medicine +4

Rows per page

1–3 of 3